Precision medicine research at Karmanos comparing biomarker
4.8 (624) · $ 17.00 · In stock
A Barbara Ann Karmanos Cancer Institute clinical researcher and her team have received $16,000 to further research in precision medicine for breast cancer treatment. Common Citizen leadership delivered the check to Jailan Elayoubi, M.D. , medical oncologist and member of the Breast Cancer and Phase 1 Clinical Trials Multidisciplinary Teams, in November 2023. Dr. Elayoubi and her team have made significant strides in studying biomarkers and tumor molecular characteristics that may predict sensitivity and
Cancers, Free Full-Text
Patient Stories
AI in early drug and biomarker discovery. (a) Deep learning
Your genes may be key in cancer fight
OECI Oncology Days: Bari, Italy, 19-21 June 2019, 2019
Combining Diagnostics & Therapeutics Pioneering Precision Medicine
Frontiers Towards Building a Quantitative Proteomics Toolbox in
Existing and novel biomarkers for precision medicine in systemic
FOX 2, The Doctor Is In: Lung Cancer Awareness
Phenotypic Biomarkers in Precision Medicine
